JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB245539

Anti-NIPBL antibody

Be the first to review this product! Submit a review

|

(2 Publications)

Rabbit Polyclonal NIPBL antibody. Suitable for IP and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Synthetic Peptide within Human NIPBL aa 550 to C-terminus.

View Alternative Names

IDN3, SCC2, NIPBL, Nipped-B-like protein, Delangin, SCC2 homolog

1 Images
Immunoprecipitation - Anti-NIPBL antibody (AB245539)
  • IP

Supplier Data

Immunoprecipitation - Anti-NIPBL antibody (AB245539)

NIPBL was immunoprecipitated from HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate (0.5 or 1 mg for IP, 20% of IP loaded) with ab245539 at 6 μg/reaction. Western blot was performed from the immunoprecipitate using a different Anti-NIPBL antibody at 1 μg/ml.

Lane 1 : ab245539 IP (Batch 1) in HeLa whole cell lysate.

Lane 2 : ab245539 IP (Batch 2) in HeLa whole cell lysate.

Lane 3 : Control IgG IP in HeLa whole cell lysate.

Detection : Chemiluminescence with an exposure time of 3 seconds.

Lysates prepared in NETN buffer.

All lanes:

Immunoprecipitation - Anti-NIPBL antibody (ab245539)

Predicted band size: 316 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP

applications

Immunogen

Synthetic Peptide within Human NIPBL aa 550 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q6KC79

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "2-10 µg/mg of lysate", "IP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
ab245539 was affinity purified using an epitope specific to NIPBL immobilized on solid support.
Storage buffer
pH: 7 - 8 Preservative: 0.09% Sodium azide Constituents: Tris citrate/phosphate
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Plays an important role in the loading of the cohesin complex on to DNA. Forms a heterodimeric complex (also known as cohesin loading complex) with MAU2/SCC4 which mediates the loading of the cohesin complex onto chromatin (PubMed : 22628566, PubMed : 28914604). Plays a role in cohesin loading at sites of DNA damage. Its recruitment to double-strand breaks (DSBs) sites occurs in a CBX3-, RNF8- and RNF168-dependent manner whereas its recruitment to UV irradiation-induced DNA damage sites occurs in a ATM-, ATR-, RNF8- and RNF168-dependent manner (PubMed : 28167679). Along with ZNF609, promotes cortical neuron migration during brain development by regulating the transcription of crucial genes in this process. Preferentially binds promoters containing paused RNA polymerase II. Up-regulates the expression of SEMA3A, NRP1, PLXND1 and GABBR2 genes, among others (By similarity).
See full target information NIPBL

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Communications biology 7:206 PubMed38378967

2024

NIPBL-mediated RAD21 facilitates tumorigenicity by the PI3K pathway in non-small-cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoling Xu,Ding Wang,Weizhen Xu,Huihui Li,Ning Chen,Na Li,Qifeng Yao,Wei Chen,Jianxiang Zhong,Weimin Mao

NPJ precision oncology 7:28 PubMed36922568

2023

The SMARCA4 mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xiangwei Zeng,Bing Yao,Jianpeng Liu,Guan-Wen Gong,Ming Liu,Jiahuang Li,Hua-Feng Pan,Qixiang Li,Dongjun Yang,Peifen Lu,Dongliang Wu,Peipei Xu,Bing Chen,Panhai Chen,Ming Zhang,Ke Zen,Jian Jing,David C S Huang,Dijun Chen,Zhi-Wei Jiang,Quan Zhao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com